Cite
HARVARD Citation
Wildi, L. et al. (2011). Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Annals of the rheumatic diseases. 70 (6), pp. 982-989. [Online].